Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma

10 Jun 2019

Abstract excerpt

A poor outcome for pancreatic ductal adenocarcinoma (PDAC) patients is still a challenge worldwide. The aim of our study is to investigate the potential of key laminin subunits for being used both as a diagnostic and prognostic biomarker for PDAC patients. We evaluated the mRNA expression and prognostic value of laminin gene family in PDAC tissues using online public databases. Moreover, the relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Caveolin-1 and cellular processes
Share to Cell Adhesion Molecules Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31182680
DOI: 10.18632/aging.102007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinomaPMID 31182680Read ↗

Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinomaSemantic proximity Read ↗

Overexpression of Laminin-5 Gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascadeSemantic proximity Read ↗

ITGA2, LAMB3, and LAMC2 May Be the Potential Therapeutic Targets in Pancreatic Ductal Adenocarcinoma: an Integrated Bioinformatics AnalysisSemantic proximity Read ↗

ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysisSemantic proximity Read ↗

Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

PDAC-ANN: an artificial neural network to predict Pancreatic Ductal Adenocarcinoma based on gene expressionSemantic proximity Read ↗

Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validationSemantic proximity Read ↗

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthSemantic proximity Read ↗

PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expressionSemantic proximity Read ↗

Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after PancreaticoduodenectomySemantic proximity Read ↗

RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissuesSemantic proximity Read ↗

Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.